X-154535261-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 1P and 1B. PP3BS2_Supporting
The NM_001360016.2(G6PD):c.392G>A(p.Gly131Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00000992 in 1,210,242 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001360016.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
G6PD | NM_001360016.2 | c.392G>A | p.Gly131Glu | missense_variant | Exon 5 of 13 | ENST00000393562.10 | NP_001346945.1 | |
G6PD | NM_000402.4 | c.482G>A | p.Gly161Glu | missense_variant | Exon 5 of 13 | NP_000393.4 | ||
G6PD | NM_001042351.3 | c.392G>A | p.Gly131Glu | missense_variant | Exon 5 of 13 | NP_001035810.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112094Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34286
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183370Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67902
GnomAD4 exome AF: 0.00000911 AC: 10AN: 1098148Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 4AN XY: 363506
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112094Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34286
ClinVar
Submissions by phenotype
Anemia, nonspherocytic hemolytic, due to G6PD deficiency Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 131 of the G6PD protein (p.Gly131Glu). This variant is present in population databases (rs137852341, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with G6PD-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on G6PD protein function. This variant disrupts the p.Gly131 amino acid residue in G6PD. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11243133, 11400791, 25775246). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at